Alamein Festival
16.7.2024 15:11:00 CEST | ACCESS Newswire | Press release
"Alamein Festival" runs from July 11 to early September through the Egyptian North Coast.
The festival aims to promote New Alamein City's urban development, boost tourism, and attract investment, featuring a variety of cultural, sports, and entertainment events.
60% of the festival proceeds is dedicated to the humanitarian relief in Gaza.
The success of the inaugural festival in 2023, which brought nearly 15 million tourists to Egypt, has spurred substantial investment and development in the region.
CAIRO, EGYPT / ACCESSWIRE / July 16, 2024 / "Alamein Festival", the largest and most diverse entertainment extravaganza in Egypt and the Middle East, running throughout summer on the iconic Egyptian North coast organized by the United Media Services (UMS), the leading Egyptian media conglomerate and one of the biggest in the Arab region, launched its second edition, of 2024.
To view this piece of content from cdn.nwe.io, please give your consent at the top of this page.Under the theme "The World is Alamein," this year's festival runs from July 11th through the first week of September 2024, promising a spectacular showcase of cultural richness, sportsmanship, and entertainment excellence.
The festival, supported by esteemed commercial sponsors including Egyptian Post, City Edge Real Estate Development, Ezz Steel, Gemma Ceramics, Organi Group, Urban Development Fund, Global Auto Group, National Bank of Egypt, Banque Misr, Banque du Caire, Commercial International Bank, Rixos Egypt, and Council Masters, aims to shine a spotlight on the rapid urban development of Egypt's northwest coast, particularly the burgeoning city of New Alamein. Renowned for its picturesque beaches and favourable climate, the region stands as a beacon for both local and international tourists, offering abundant investment opportunities in real estate and tourism infrastructure.
The official announcement was made at a press conference at New Alamein City, attended by Ashraf Salman, the Chairman of the Board of Directors at UMS, and Amr El-Feki, the CEO and Managing Director.
Salman underscored the festival's strategic alignment with national development goals, emphasising its pivotal role in bolstering regional tourism in Egypt. This alignment is a source of pride for all who support the festival, he said
El-Feki outlined an ambitious program for the 2024 edition, promising an array of over 20 mega events designed to cater to diverse interests and demographics. Highlights include theatrical performances curated by esteemed producers and featuring top-tier celebrities and emerging talents, sports matches showcasing football, basketball, volleyball, and padel tennis icons, and the highly anticipated Insomnia digital games competition.
In a testament to its unwavering commitment to social responsibility, UMS has pledged to allocate 60% of the festival's proceeds to support residents in Gaza, reinforcing its dedication to humanitarian aid amidst regional challenges.
UMS resolved to organise the second edition of "Alamein Festival" after its debut triumph last year, which attracted many international and regional visitors. This success significantly contributed to Egypt's achieving a record-breaking influx of nearly 15 million tourists in 2023, a landmark achievement in its tourism history.
For more information, please visit the festival website: https://elalameinfestival.com
Contact Information
Eman Salem
press@30n.org
SOURCE: Alamein Festival
To view this piece of content from stats.nwe.io, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
Preservica Redefines Digital Preservation with Powerful Built-In AI Tools4.2.2026 15:00:00 CET | Press release
OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow. "With the sheer volume of digital content in backlogs and being created daily, using AI to assist in archival tasks has now become essential" says Stuart Reed, Chief Product Officer at Preservica "Seamlessly integrating human-centered AI tools across our product editions turns AI for Digital Preservation into reality - enabling organizations of all sizes to accelerate routine work, cut backlogs and enhance discovery." Developed in collaboration with Preservica's user community and refined through the company's highly rated AI Workshop series, these embedded to
Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press release
CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a
Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press release
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in
CHAR Technologies Licenses High-Temperature Pyrolysis Technology to GazoTech SAS for Entry Into European Markets4.2.2026 14:00:00 CET | Press release
TORONTO, ON / ACCESS Newswire / February 4, 2026 / CHAR Technologies Ltd. ("CHAR Tech" or "the Company") (TSXV:YES)(FSE:68K) a leader in sustainable biomass energy solutions, today announced that it has entered into a formal technology know-how licensing agreement with GazoTech SAS ("GazoTech"), a France-based energy developer, to support deployment of CHAR Tech's technology in France and selected European markets. The agreement follows recent commissioning progress at CHAR Tech's Thorold Renewable Energy Facility and complements the Company's ongoing development of larger-scale projects in North America. Under the agreement, CHAR Tech is the licensor of its proprietary High-Temperature Pyrolysis ("HTP") technology, granting GazoTech a know-how licence for projects developed in France as well as certain additional European markets, subject to project-by-project application of the licenced technology. GazoTech has multiple projects in development in France, notably: An industrial integr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom